Wednesday, November 26, 2014
Inquirer Daily News

Daniel Hoffman

Clinical R&D deserves more due diligence

Monday, February 11, 2013, 12:01 PM
Late last month Citigroup published its 2013 overview for pharma, "Global Healthcare Road Ahead: 2013 Outlook." It constitutes a sobering counterview to the touts and boosters from those in the investment community who tried to prop up the recent earnings reports. The critical challenge for pharma... Read more

Pharma's clinical development at cross purposes with itself

Tuesday, January 22, 2013, 9:00 AM
Developing new products through clinical trials represents the lifeblood of branded pharmaceuticals. Unless companies can develop new products to replace the existing ones that lose patent protection, their revenues will erode as payers and patients fill prescriptions with less expensive generics... Read more

Social networks among trial sites set the pace of patient recruitment

Tuesday, January 8, 2013, 9:00 AM
Last October we reviewed some KMR data, combined it with our own findings (see here) and concluded that while the industry's overall productivity at developing new drugs has not substantially changed during the past decade, the period between starting a compound's clinical trials and its registration... Read more

Pharma facts 2012: Behind the curve on important health care changes

Saturday, January 5, 2013, 10:00 AM
Editor’s Note: All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into health care changes. One of this year's memorable expressions came from a wise fellow at a major software company... Read more

Pharma facts 2012: Pharma wants the right to cry fire in a crowded theater

Friday, January 4, 2013, 10:00 AM
Editor’s Note: All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into Pharma's right to promote drugs. This month the US 2nd Circuit Court of Appeals (New York, Connecticut, Vermont)... Read more

Pharma facts 2012: Health Care is the Real Fiscal Cliff

Thursday, January 3, 2013, 10:00 AM
Editor’s Note: All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into the worries of the new health care. Health care costs already devour 18% of America's GDP. Between now and... Read more

Pharma facts 2012: The entire approach to cancer therapy may be ineffective

Wednesday, January 2, 2013, 10:00 AM
Editor’s Note: All this week Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into Pharma’s approach to cancer therapy. For a decade or more pharma's researchers have believed that the... Read more

Pharma facts 2012: Health care premiums will go up, way, way up

Tuesday, January 1, 2013, 10:00 AM
Editor’s Note: As the year draws to a close, over the next four days, Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into health care premiums. This month the CEO at Aetna, one of the US's... Read more

Tis' the season for pharma's tricks

Friday, December 21, 2012, 12:40 PM
The Christmas season is one of enchantment, myth, childhood wishes and the noble spirit of peace on earth and good will toward all men. It remains for pharma to bring us back to hard reality. During a year-end flourish, several companies have acknowledged their illegal kickbacks to physicians, off-label... Read more

Pharma's "Vision" for the Future or Three Blind Mice?

Tuesday, December 4, 2012, 2:26 PM
By Daniel R. Hoffman, Ph.D. Last month the pharma columnist at Forbes, Matthew Herper, wrote that after "talking to executives around the drug industry," most are pursuing one of the following three alternative scenarios: The blockbuster model, the expanded orphan strategy and the access model. Here... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Latest Health Videos
Also on Philly.com:
Stay Connected